Uzair Khalid Muhammad, Khan Shawn, Koerber Daniel, Ashok Shah Hemant
Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Can Liver J. 2022 Nov 7;5(4):513-529. doi: 10.3138/canlivj-2022-0018. eCollection 2022 Nov.
Hepatitis C (HCV) places a disproportionately higher burden on the South Asian community in comparison to the general population, despite the availability of effective antiviral therapies. This study seeks to characterize the effectiveness of health promotion initiatives aimed at South Asians to improve HCV prevention, education, screening, and treatment adherence. A systematic review (PROSPERO: CRD42021253796) was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. Ovid MEDLINE, CINAHL Plus, Web of Science, ERIC, Ovid Embase, Cochrane Library, and PsycINFO were searched from inception to 15 April 2022 for original studies that reported on any health promotion initiative directed at improving HCV outcomes in the South Asian community. Risk of bias was assessed via a quality score. A total of 15 studies (6 uncontrolled interventional, 3 before-after interventional, 3 randomized controlled, 2 prospective cohort, and 1 historically controlled interventional study designs) involving 69,958 participants were included. The most studied interventions were formal HCV teaching ( = 12), community outreach ( = 6), and coupling screening/testing with existing programs ( = 3). Ninety-two percent (14/15) of interventions were concluded to be successful, and 71% (10/14) of those were concluded to be feasible and/or cost-effective. Interventions that aim to improve HCV education and accessibility to screening/treatment can substantially reduce barriers to care in South Asian communities. Further research, of higher quality RCT evidence, is needed to study the long-term reduction in HCV prevalence from these proposed interventions, and their associated feasibility profiles.
尽管有有效的抗病毒治疗方法,但与普通人群相比,丙型肝炎(HCV)给南亚社区带来的负担 disproportionately 更高。本研究旨在描述针对南亚人的健康促进举措在改善 HCV 预防、教育、筛查和治疗依从性方面的有效性。根据系统评价和 Meta 分析的首选报告项目指南进行了一项系统评价(PROSPERO:CRD42021253796)。从创刊到 2022 年 4 月 15 日,对 Ovid MEDLINE、CINAHL Plus、Web of Science、ERIC、Ovid Embase、Cochrane 图书馆和 PsycINFO 进行了检索,以查找报告任何旨在改善南亚社区 HCV 结局的健康促进举措的原始研究。通过质量评分评估偏倚风险。总共纳入了 15 项研究(6 项非对照干预研究、3 项前后干预研究、3 项随机对照研究、2 项前瞻性队列研究和 1 项历史对照干预研究设计),涉及 6,9958 名参与者。研究最多的干预措施是正式的 HCV 教学(=12)、社区外展(=6)以及将筛查/检测与现有项目相结合(=3)。92%(14/15)的干预措施被认为是成功的,其中 71%(10/14)被认为是可行的和/或具有成本效益的。旨在改善 HCV 教育以及筛查/治疗可及性的干预措施可以大幅减少南亚社区的护理障碍。需要进一步开展更高质量的随机对照试验证据研究,以探讨这些拟议干预措施对 HCV 患病率的长期降低效果及其相关的可行性概况。